HEPREGEN
Hepregen Corporation is pursuing applications of its microliver platform for acute and chronic toxicity as well as for understanding the metabolism of drugs in the liver. Applications in the pharmaceutical industry may well extend beyond toxicity and metabolism to include utility in drug discovery, disease modeling (obesity, infectious disease, diabetes), in silico models, and toxicogenomics. Hepregen is actively engaged in industrial collaborations to validate the microliver platform in a wide spectrum of applications. The combined markets for Hepregen's microliver platform is approximately a billion dollars annually.
HEPREGEN
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2007-01-01
Address:
Medford, Massachusetts, United States
Country:
United States
Website Url:
http://www.hepregen.com
Total Employee:
11+
Status:
Active
Contact:
7813910315
Email Addresses:
[email protected]
Total Funding:
4.5 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Google Maps Microsoft Azure DNS Google Google Maps API Google Cloud Hubspot Forms
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Current Employees Featured
Founder
Investors List
Massachusetts Life Sciences Center
Massachusetts Life Sciences Center investment in Grant - Hepregen
Battelle Ventures
Battelle Ventures investment in Grant - Hepregen
Innovation Valley Partners
Innovation Valley Partners investment in Series A - Hepregen
Battelle Ventures
Battelle Ventures investment in Series A - Hepregen
Official Site Inspections
http://www.hepregen.com
- Host name: 136.184.190.35.bc.googleusercontent.com
- IP address: 35.190.184.136
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Hepregen"
Hepregen - Crunchbase Company Profile & Funding
Hepregen Corporation is pursuing applications of its microliver platform for acute and chronic toxicity as well as for understanding the metabolism of drugs in the liver. Applications in the …See details»
Hepregen Corporation
Hepregen Corporation is a manufacturer of unique and proprietary bioengineered micro-liver platforms for use in environmental testing, preventive care, and product development in the …See details»
Hepregen Corporation - LinkedIn
Hepregen Corporation | 548 followers on LinkedIn. The mission of Hepregen Corporation is to transform safety assessment and drug development in order to significantly impact patients’ lives. The ...See details»
Hepregen Company Profile 2024: Valuation, Investors ... - PitchBook
Hepregen General Information Description. Developer of bio-engineering technology designed to transform safety assessment and drug development. The company's technology is used to …See details»
Hepregen Corporation Information - RocketReach
The mission of Hepregen Corporation is to transform safety assessment and drug development in order to significantly impact patients’ lives. The company is focused on advancing and …See details»
Hepregen Corp - Company Profile and News - Bloomberg Markets
Company profile page for Hepregen Corp including stock price, company news, executives, board members, and contact informationSee details»
Hepregen Corporation - Company Profile & Staff Directory
The mission of Hepregen Corporation is to transform safety assessment and drug development in order to significantly impact patients’ lives. The company is focused on advancing and …See details»
Hepregen - Funding, Financials, Valuation & Investors - Crunchbase
Hepregen Corporation is a biotechnology company that focuses on understanding the metabolism of drugs in the liver. Search Crunchbase. Start Free Trial . ... How much funding has this …See details»
Hepregen - VentureRadar
Hepregen Corporation is developing bioengineered solutions for drug development, including a platform for advanced toxicity screening and drug discovery. With its high fidelity model of the …See details»
Hepregen - Crunchbase
Hepregen Corporation is a biotechnology company that focuses on understanding the metabolism of drugs in the liver.See details»
Hepregen - Products, Competitors, Financials, Employees, …
Hepregen, a spinout of MIT, is developing a platform to reduce the liver toxicity caused by approved drugs. Use the CB Insights Platform to explore Hepregen's full profile. ... Sword Bio …See details»
Hepregen - Company Profile - Tracxn
Hepregen - HepatoPac® and HepatoMune™ liver models (in vitro tools) for assessing drug metabolism & potential hepatotoxicity. Raised a total funding of $3M over 4 rounds from 4 …See details»
Hepregen - EquityNet
Hepregen Corporation is pursuing applications of its microliver platform for acute and chronic toxicity as well as for understanding the metabolism of drugs in the liver. Applications in the …See details»
6 Companies Building Organs on a Chip - Nanalyze
Sep 6, 2015 Hepregen was spun out of MIT in 2008 and funded with a Series A round of $3 million. Since then, they took in an additional $1.5 million in grants bringing their total funding …See details»
BioIVT acquires Hepregen - 2018-03-27 - Crunchbase
Mar 27, 2018 Hepregen Hepregen Corporation is a biotechnology company that focuses on understanding the metabolism of drugs in the liver. Acquiring Organization: BioIVT BioIVT is a …See details»
Putting liver on a chip | Drug Discovery News
Apr 6, 2009 Hepregen has determined that micro-patterned co-cultures (cell-cell interactions) have a critical role in tissue organization leading to long-term stability of the liver cells. …See details»
Hepregen - Contacts, Employees, Board Members, Advisors
Hepregen has 2 current employee profiles, including Director, Research Salman Khetani. Salman Khetani Director, Research Bernadette C. Fendrock President and CEOSee details»
Hepregen Corporation | Medford MA - Facebook
Hepregen Corporation, Medford, Massachusetts. 266 likes. Hepregen Corporation is developing bioengineered solutions for drug development, including a platform for advanced toxicity screening and drug...See details»
Bernadette C. Fendrock - President and CEO @ Hepregen
Ms. Bernadette C. Fendrock is co-founder, president and CEO of Hepregen. Ms. Fendrock comes to Hepregen with experience as Vice President at Genzyme Corporation, Director of Business …See details»
Hepregen - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 24, 2024 Hepregen uses 16 technology products and services including HTML5, Microsoft Outlook, and Wordpress, according to G2 Stack. Hepregen is actively using 9 technologies for …See details»